Similarly, it has also been reported that celastrol ameliorated NAFLD by SIRT1 pathway, which had an important role in improving liver metabolic injury induced by HFD (Zhang et al., 2016). Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.